))
Viracta and Burgeon Brewing Company
Manage episode 324973178 series 2971598
Content provided by Daniel Schroeder. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Daniel Schroeder or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
In this episode of The Biotech and Breweries Podcast, Noah Scoville, Manager at Burgeon Brewing, shares four beers from the craft beer brewery: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press.
Dan Chevallard, COO and Chief Financial Officer of Viracta shares his journey with Viracta and their pursuit of EBV-associated cancers with a combination drug product. He discusses the evolution of Viracta as a company, their targeted approach to merging oncology with virology, and how to fundraise with a bridge mentality and not a pyramid mentality.
Quotes:
“Community is such a core thing for us and making great beer is a huge thing as well. Without good beer, especially in San Diego with 160 different breweries, you’re kind of gonna get drowned out. There is a lot of noise. So you’ve got to have great beer to separate yourself from the others.” - Noah Scoville [03:38]
“For an individual who is trying to start a company: have a mentor. You have to have someone you can talk to that’s seen it, done and that you can bounce ideas off of. Operating in a silo is not ideal.” - Dan Chevallard [34:01]
Topics discussed:
- Burgeon Beer
- Brews: Invita Mexican Lager, Carlsbad Crush, Treevana IPA, and Juice Press
- Dan’s journey in BioScience
- Viracta’s progress
- The intersection of Oncology and Virology
- Accessing the public market
- Dan’s fundraising advice
Resources:
Connect with Viracta:
Connect with Burgeon Brewing:
SUBSCRIBE: Subscribe to the podcast to make sure you never miss an episode.
18 episodes
Share
